{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:39:15Z","timestamp":1785523155000,"version":"3.56.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD115810"],"award-info":[{"award-number":["R01HD115810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES032144"],"award-info":[{"award-number":["R01ES032144"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01ES035766"],"award-info":[{"award-number":["R01ES035766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30ES005022"],"award-info":[{"award-number":["P30ES005022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The remarkable advances in cancer therapies significantly enhance the survival rates and longevity of cancer patients. Among childhood, adolescent, and young adult female cancer survivors, however, anti-cancer agents frequently cause primary ovarian insufficiency, early menopause, and infertility, primarily due to the depletion of the ovarian reserve. Oocytes, the female germ cells, exhibit a notable susceptibility to DNA damage, given that they remain in meiotic arrest at prophase I for prolonged durations, from months to years, which increases the risks of accumulating DNA damage overtime. To counteract this, a tightly controlled DNA damage response signaling ensures that only oocytes with an intact genome progress to ovulation, fertilization, and next generations. Chemotherapeutic anti-cancer agents, including doxorubicin, cisplatin, cyclophosphamide, along with irradiation, elicit DNA damage via various mechanisms, including DNA crosslinking, single- and double-strand DNA breaks, and oxidative stress. The genotoxic insults activate DDR in the oocytes, which detect and repair DNA damage or initiate apoptosis to eliminate impaired oocytes. Although several protein molecules such as DNA damage-sensing kinases, checkpoint kinases, p53 family transcription factors, and pro-apoptotic molecules have been discovered, the precise mechanisms of DDR in determining the fate of oocytes, particularly how they differ from those in somatic cells and cancer cells, remain poorly understood. From an oncofertility perspective, the current review analyzes the molecular mechanisms of anti-cancer agent-induced DDR in oocytes and discusses knowledge gaps and urgent future research directions for preserving the ovarian reserve, fertility, and endocrine functions of young female cancer patients.<\/jats:p>","DOI":"10.1093\/biolre\/ioaf207","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:12:45Z","timestamp":1757679165000},"page":"1-11","source":"Crossref","is-referenced-by-count":2,"title":["DNA damage response signaling in oocytes from an oncofertility perspective"],"prefix":"10.1093","volume":"114","author":[{"given":"Yunman (Sonia)","family":"Song","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University , Piscataway, New Jersey ,","place":["United States"]},{"name":"Environmental and Occupational Health Sciences Institute (EOHSI) , Piscataway, New Jersey ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5354-6221","authenticated-orcid":false,"given":"Jiyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University , Piscataway, New Jersey ,","place":["United States"]},{"name":"Environmental and Occupational Health Sciences Institute (EOHSI) , Piscataway, New Jersey ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Bo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University , Piscataway, New Jersey ,","place":["United States"]},{"name":"Environmental and Occupational Health Sciences Institute (EOHSI) , Piscataway, New Jersey ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-7013","authenticated-orcid":false,"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University , Atlanta, Georgia ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-6852","authenticated-orcid":false,"given":"So-Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"Olson Center for Women\u2019s Health, Department of Obstetrics and Gynecology, College of Medicine, University of Nebraska Medical Center , Omaha, Nebraska ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-9132","authenticated-orcid":false,"given":"Shuo","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University , Piscataway, New Jersey ,","place":["United States"]},{"name":"Environmental and Occupational Health Sciences Institute (EOHSI) , Piscataway, New Jersey ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"2026011601320143500_ref1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41418-018-0151-2","article-title":"Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies","volume":"26","author":"Kim","year":"2019","journal-title":"Cell Death Differ"},{"key":"2026011601320143500_ref2","doi-asserted-by":"publisher","first-page":"13885","DOI":"10.1096\/fj.202001461RR","article-title":"Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation","volume":"34","author":"Eldani","year":"2020","journal-title":"FASEB J"},{"key":"2026011601320143500_ref3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fgene.2015.00308","article-title":"Genetics of the ovarian reserve","volume":"6","author":"Pelosi","year":"2015","journal-title":"Front Genet"},{"key":"2026011601320143500_ref4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1095\/biolreprod.115.133652","article-title":"How is the number of primordial follicles in the ovarian reserve established?","volume":"93","author":"Findlay","year":"2015","journal-title":"Biol Reprod"},{"key":"2026011601320143500_ref5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/B978-0-12-416024-8.00007-6","article-title":"The control of meiotic maturation in mammalian oocytes","volume":"102","author":"Holt","year":"2013","journal-title":"Curr Top Dev Biol"},{"key":"2026011601320143500_ref6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fgene.2013.00117","article-title":"The DNA damage response in mammalian oocytes","volume":"4","author":"Carroll","year":"2013","journal-title":"Front Genet"},{"key":"2026011601320143500_ref7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/molehr\/gaz020","article-title":"Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes","volume":"25","author":"Nguyen","year":"2019","journal-title":"Mol Hum Reprod"},{"key":"2026011601320143500_ref8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"2026011601320143500_ref9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"2026011601320143500_ref10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"2026011601320143500_ref11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.radonc.2013.06.013","article-title":"Ionizing-radiation induced DNA double-strand breaks: a direct and indirect lighting up","volume":"108","author":"Vignard","year":"2013","journal-title":"Radiother Oncol"},{"key":"2026011601320143500_ref12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12958-024-01273-z","article-title":"Molecular regulation of DNA damage and repair in female infertility: a systematic review","volume":"22","author":"Xu","year":"2024","journal-title":"Reprod Biol Endocrinol"},{"key":"2026011601320143500_ref13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25235714","article-title":"DNA damaged induced cell death in oocytes","volume":"25","author":"Gebel","year":"2020","journal-title":"Molecules"},{"key":"2026011601320143500_ref14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature05337","article-title":"p63 protects the female germ line during meiotic arrest","volume":"444","author":"Suh","year":"2006","journal-title":"Nature"},{"key":"2026011601320143500_ref15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","article-title":"DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa","volume":"48","author":"Kerr","year":"2012","journal-title":"Mol Cell"},{"key":"2026011601320143500_ref16","doi-asserted-by":"crossref","first-page":"eade1846","DOI":"10.1126\/sciadv.ade1846","article-title":"TAp63 determines the fate of oocytes against DNA damage","volume":"8","author":"Luan","year":"2022","journal-title":"Sci Adv"},{"key":"2026011601320143500_ref17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"2026011601320143500_ref18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"2026011601320143500_ref19","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N Engl J Med"},{"key":"2026011601320143500_ref20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol Cell"},{"key":"2026011601320143500_ref21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.neuroscience.2006.08.061","article-title":"DNA repair, mitochondria, and neurodegeneration","volume":"145","author":"Weissman","year":"2007","journal-title":"Neuroscience"},{"key":"2026011601320143500_ref22","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.dnarep.2008.03.006","article-title":"The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle","volume":"7","author":"Biton","year":"2008","journal-title":"DNA Repair (Amst)"},{"key":"2026011601320143500_ref23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A single ataxia telangiectasia gene with a product similar to PI-3 kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"2026011601320143500_ref24","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1093\/emboj\/cdg541","article-title":"Requirement of the MRN complex for ATM activation by DNA damage","volume":"22","author":"Uziel","year":"2003","journal-title":"EMBO J"},{"key":"2026011601320143500_ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/bmb\/ldl006","article-title":"Primary immunodeficiency syndromes associated with defective DNA double-strand break repair","volume":"77-78","author":"Gennery","year":"2006","journal-title":"Br Med Bull"},{"key":"2026011601320143500_ref26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/humu.20408","article-title":"RAG-dependent primary immunodeficiencies","volume":"27","author":"Sobacchi","year":"2006","journal-title":"Hum Mutat"},{"key":"2026011601320143500_ref27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tibs.2011.10.002","article-title":"The ATM protein kinase and cellular redox signaling: beyond the DNA damage response","volume":"37","author":"Ditch","year":"2012","journal-title":"Trends Biochem Sci"},{"key":"2026011601320143500_ref28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cmet.2013.06.019","article-title":"Metabolic regulation by p53 family members","volume":"18","author":"Berkers","year":"2013","journal-title":"Cell Metab"},{"key":"2026011601320143500_ref29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tig.2007.11.004","article-title":"Age to survive: DNA damage and aging","volume":"24","author":"Schumacher","year":"2008","journal-title":"Trends Genet"},{"key":"2026011601320143500_ref30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.18632\/aging.100667","article-title":"Aging and DNA damage in humans: a meta-analysis study","volume":"6","author":"Soares","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"2026011601320143500_ref31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"key":"2026011601320143500_ref32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature19329","article-title":"Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice","volume":"537","author":"Vermeij","year":"2016","journal-title":"Nature"},{"key":"2026011601320143500_ref33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/humupd\/dmz043","article-title":"BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging","volume":"26","author":"Turan","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2026011601320143500_ref34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10815-015-0483-5","article-title":"Increased DNA damage and repair deficiency in granulosa cells are associated with ovarian aging in rhesus monkey","volume":"32","author":"Zhang","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2026011601320143500_ref35","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/REP-21-0022","article-title":"Mechanisms of ovarian aging","volume":"162","author":"Park","year":"2021","journal-title":"Reproduction"},{"key":"2026011601320143500_ref36","doi-asserted-by":"crossref","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026011601320143500_ref37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-021-03779-7","article-title":"Genetic insights into biological mechanisms governing human ovarian ageing","volume":"596","author":"Ruth","year":"2021","journal-title":"Nature"},{"key":"2026011601320143500_ref38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol Cell"},{"key":"2026011601320143500_ref39","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrc2054","article-title":"Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations","volume":"7","author":"Fackenthal","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2026011601320143500_ref40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"2026011601320143500_ref41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"2026011601320143500_ref42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1158\/2159-8290.CD-11-0320","article-title":"Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1","volume":"2","author":"Aarts","year":"2012","journal-title":"Cancer Discov"},{"key":"2026011601320143500_ref43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153819","article-title":"Proteins from the DNA damage response: regulation, dysfunction, and anticancer strategies","volume":"13","author":"Molinaro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026011601320143500_ref44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/REP-11-0430","article-title":"The primordial follicle reserve is not renewed after chemical or \u03b3-irradiation mediated depletion","volume":"143","author":"Kerr","year":"2012","journal-title":"Reproduction"},{"key":"2026011601320143500_ref45","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis"},{"key":"2026011601320143500_ref46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/1754-9485.13413","article-title":"Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy","volume":"66","author":"Czajkowski","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2026011601320143500_ref47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgn250","article-title":"Base excision repair of oxidative DNA damage and association with cancer and aging","volume":"30","author":"Maynard","year":"2009","journal-title":"Carcinogenesis"},{"key":"2026011601320143500_ref48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41594-018-0035-7","article-title":"Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63","volume":"25","author":"Tuppi","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"2026011601320143500_ref49","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/humrep\/dep224","article-title":"Expression profiling of DNA repair genes in human oocytes and blastocysts using microarrays","volume":"24","author":"Jaroudi","year":"2009","journal-title":"Hum Reprod"},{"key":"2026011601320143500_ref50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1095\/biolreprod.104.039073","article-title":"Developmental regulation and in vitro culture effects on expression of DNA repair and cell cycle checkpoint control genes in rhesus monkey oocytes and embryos","volume":"72","author":"Zheng","year":"2005","journal-title":"Biol Reprod"},{"key":"2026011601320143500_ref51","doi-asserted-by":"publisher","first-page":"11513","DOI":"10.1073\/pnas.2001124117","article-title":"Oocytes can efficiently repair DNA double-strand breaks to restore genetic integrity and protect offspring health","volume":"117","author":"Stringer","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026011601320143500_ref52","doi-asserted-by":"publisher","first-page":"e13384","DOI":"10.1111\/cpr.13384","article-title":"Selective utilization of non-homologous end-joining and homologous recombination for DNA repair during meiotic maturation in mouse oocytes","volume":"56","author":"Lee","year":"2023","journal-title":"Cell Prolif"},{"key":"2026011601320143500_ref53","doi-asserted-by":"publisher","first-page":"810928","DOI":"10.3389\/fcell.2021.810928","article-title":"Increased WIP1 expression with aging suppresses the capacity of oocytes to respond to and repair DNA damage","volume":"9","author":"Leem","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026011601320143500_ref54","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1016\/j.cub.2024.09.040","article-title":"Changes in DNA repair compartments and cohesin loss promote DNA damage accumulation in aged oocytes","volume":"34","author":"Sharma","year":"2024","journal-title":"Curr Biol"},{"key":"2026011601320143500_ref55","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"2026011601320143500_ref56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/cdd.2016.97","article-title":"LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse","volume":"24","author":"Rossi","year":"2017","journal-title":"Cell Death Differ"},{"key":"2026011601320143500_ref57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J Endocrinol"},{"key":"2026011601320143500_ref58","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"2026011601320143500_ref59","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"2026011601320143500_ref60","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.2889","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat Med"},{"key":"2026011601320143500_ref61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41467-020-20669-0","article-title":"The p63 C-terminus is essential for murine oocyte integrity","volume":"12","author":"Lena","year":"2021","journal-title":"Nat Commun"},{"key":"2026011601320143500_ref62","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41589-020-0600-3","article-title":"p63 uses a switch-like mechanism to set the threshold for induction of apoptosis","volume":"16","author":"Gebel","year":"2020","journal-title":"Nat Chem Biol"},{"key":"2026011601320143500_ref63","doi-asserted-by":"publisher","first-page":"14617","DOI":"10.1073\/pnas.0507322102","article-title":"Multisite protein phosphorylation makes a good threshold but can be a poor switch","volume":"102","author":"Gunawardena","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026011601320143500_ref64","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41419-024-07202-7","article-title":"Oocyte death is triggered by the stabilization of TAp63\u03b1 dimers in response to cisplatin","volume":"15","author":"Abazarikia","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026011601320143500_ref65","doi-asserted-by":"publisher","first-page":"e70117","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PloS One"},{"key":"2026011601320143500_ref66","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41419-018-1026-7","article-title":"C-Abl is not act\u0131vated in DNA damage-induced and Tap63-mediated oocyte apoptos\u0131s in human ovary","volume":"9","author":"Bildik","year":"2018","journal-title":"Cell Death Dis"},{"key":"2026011601320143500_ref67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2014.03.006","article-title":"Involvement of a volatile metabolite during phosphoramide mustard-induced ovotoxicity","volume":"277","author":"Madden","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026011601320143500_ref68","doi-asserted-by":"publisher","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \"burnout\"; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026011601320143500_ref69","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.4161\/cc.26358","article-title":"Ovarian follicle burnout: a universal phenomenon?","volume":"12","author":"Roness","year":"2013","journal-title":"Cell Cycle"},{"key":"2026011601320143500_ref70","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","article-title":"Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro","volume":"34","author":"Lande","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2026011601320143500_ref71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13048-017-0350-3","article-title":"Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo","volume":"10","author":"Zhou","year":"2017","journal-title":"J Ovarian Res"},{"key":"2026011601320143500_ref72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41598-020-79643-x","article-title":"Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation","volume":"11","author":"Titus","year":"2021","journal-title":"Sci Rep"},{"key":"2026011601320143500_ref73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.taap.2015.12.010","article-title":"The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion","volume":"292","author":"Ganesan","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026011601320143500_ref74","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"2026011601320143500_ref75","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"2026011601320143500_ref76","doi-asserted-by":"crossref","first-page":"e42293","DOI":"10.1371\/journal.pone.0042293","article-title":"Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent","volume":"7","author":"Roti Roti","year":"2012","journal-title":"PloS One"},{"key":"2026011601320143500_ref77","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/toxsci\/kfx047","article-title":"Doxorubicin has dose-dependent toxicity on mouse ovarian follicle development, hormone secretion, and oocyte maturation","volume":"157","author":"Xiao","year":"2017","journal-title":"Toxicol Sci"},{"key":"2026011601320143500_ref78","doi-asserted-by":"publisher","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"2026011601320143500_ref79","doi-asserted-by":"publisher","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026011601320143500_ref80","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/nm1197-1228","article-title":"Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction","volume":"3","author":"Perez","year":"1997","journal-title":"Nat Med"},{"key":"2026011601320143500_ref81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yrtph.2017.02.012","article-title":"Effect of doxorubicin-induced ovarian toxicity on mouse ovarian granulosa cells","volume":"86","author":"Zhang","year":"2017","journal-title":"Regul Toxicol Pharmacol"},{"key":"2026011601320143500_ref82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026011601320143500_ref83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1530\/REP-07-0054","article-title":"p63 null mutation protects mouse oocytes from radio-induced apoptosis","volume":"135","author":"Livera","year":"2008","journal-title":"Reproduction"},{"key":"2026011601320143500_ref84","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.1247671","article-title":"Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway","volume":"343","author":"Bolcun-Filas","year":"2014","journal-title":"Science"},{"key":"2026011601320143500_ref85","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2011.01.013","article-title":"DNA damage in oocytes induces a switch of the quality control factor TAp63\u03b1 from dimer to tetramer","volume":"144","author":"Deutsch","year":"2011","journal-title":"Cell"},{"key":"2026011601320143500_ref86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","article-title":"The radiosensitivity of the human oocyte","volume":"18","author":"Wallace","year":"2003","journal-title":"Hum Reprod"},{"key":"2026011601320143500_ref87","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1534\/genetics.117.203455","article-title":"Pharmacological inhibition of the DNA damage checkpoint prevents radiation-induced oocyte death","volume":"206","author":"Rinaldi","year":"2017","journal-title":"Genetics"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioaf207\/64257224\/ioaf207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/114\/1\/1\/64257224\/ioaf207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/114\/1\/1\/64257224\/ioaf207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:32:08Z","timestamp":1768545128000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/114\/1\/1\/8252834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2026,1,11]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioaf207","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,9,12]]}}}